ETIHX Mutual Fund

ETIHX Mutual Fund

NAV$53.24
See how much of ETIHX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$1.3B
Expense Ratio
1.31%
Dividend Yield (Current)
-
Holdings
92
Inception Date
Dec 27, 2012
Fund Family
Eventide
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.21%
1 Year+14.57%
3 Year+21.17%
5 Year+3.86%
10 Year+13.48%

Asset Allocation

Stocks: 90.58%
Bonds: 0.34%
Cash: 1.44%
Other: 7.65%
See how much of ETIHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
GHGuardant Health, Inc5.37%
-Us Bank Mmda - Usbgfs 93.75%
MIRMMirum Pharmaceuticals, Inc.3.47%
KYMRKymera Therapeutics Inccommon Stock3.22%
ABVXAbivax Sa-Adr2.94%
Top 10 Concentration: 32.43%Report Date: Jun 30, 2026
Download all 92 holdings for ETIHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$4.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ETIHX Mutual Fund Overview

ETIHX Mutual Fund (Eventide Healthcare & Life Sciences Fund Class I) is managed by Eventide with $1.33B in net assets. ETIHX expense ratio is 1.31%, holding 92 positions across sectors including Health Care. Inception date: 2012-12-27.

ETIHX performance shows a YTD return of 4.21%. The 1-year return is 14.57% and the 5-year return is 3.86%.

ETIHX top holdings include Guardant Health, Inc (5.4%), Us Bank Mmda - Usbgfs 9 (3.8%), Mirum Pharmaceuticals, Inc. (3.5%), Kymera Therapeutics Inccommon Stock (3.2%), Abivax Sa-Adr (2.9%). Go to all ETIHX holdings, ETIHX sectors, or ETIHX dividends.

ETIHX can be compared against other funds. Use ETIHX overlap to find shared positions, or ETIHX vs another fund for a side-by-side view. ETIHX alternatives are available via the screener, along with tax-loss harvesting opportunities.